SI-BONE, Inc. is a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy. The Company specializes in minimally invasive surgical implant systems to address sacroiliac joint dysfunction as well as address unmet clinical needs in pelvic fixation and management of pelvic fractures. The Company's products include a series of patented titanium implants and the instruments used to implant them, as well as implantable bone products. Its products include iFuse, iFuse-3D, iFuse-TORQ and iFuse Bedrock Granite. Within the United States, iFuse, iFuse-3D and iFuse-TORQ have clearances for applications across sacroiliac joint dysfunction and fusion, adult spinal deformity and degeneration, and pelvic trauma. Its first-generation iFuse, a machined triangular titanium implant, has a triangular cross section that resists twisting or rotation of the implant. The Company's second generation iFuse product, the iFuse-3D implant, is a patented titanium implant.
企業コードSIBN
会社名SI-BONE Inc
上場日Oct 17, 2018
最高経営責任者「CEO」Ms. Laura A. Francis
従業員数349
証券種類Ordinary Share
決算期末Oct 17
本社所在地471 El Camino Real, Suite 101
都市SANTA CLARA
証券取引所Moscow Interbank Currency Exchange (MICEX)
国United States of America
郵便番号95050
電話番号14082070700
ウェブサイトhttps://si-bone.com/
企業コードSIBN
上場日Oct 17, 2018
最高経営責任者「CEO」Ms. Laura A. Francis
過去5年間の配当金総支払額は
0.00
米ドルである。

データなし